Sarah T. K. Sin, Yan Li, Ming Liu, Yun‐Fei Yuan, Stephanie Ma, Xin‐Yuan Guan – 2 October 2018 – Hepatocellular carcinoma (HCC) is one of the most common and lethal cancer types worldwide, especially in Asian countries. Genetic alterations, including hyperactivation of oncogenes and loss of expression of tumor suppressor genes, greatly contribute to the initiation and progression of HCC. Here we report that down‐regulation of trophoblast cell surface antigen 2 (TROP‐2) was frequently detected in HCC.

Miguel H. Malespin – 2 October 2018

Uyen Kim To, Guadalupe Garcia‐Tsao – 2 October 2018

Kevin M. Rank, John Lake – 2 October 2018

Jemma Mildon, Johann Willers, Sam J. Thomson – 2 October 2018

Uyen Kim To, Guadalupe Garcia‐Tsao – 2 October 2018

Tatyana Kushner, Jennifer Cohen, Phyllis C. Tien, Norah A. Terrault – 1 October 2018 – There is a rising prevalence of hepatitis C (HCV) among women of child‐bearing age nationally, which prompted a recommendation by national guidelines to screen all women for HCV during pregnancy. Women with HCV during pregnancy are at risk of perinatal transmission of HCV. Directly acting antiviral (DAA) therapy during pregnancy can potentially reduce the risk of perinatal transmission as well as cure women while they are engaged in antenatal care.

1 October 2018

Ronald L. Koretz, Janus C. Jakobsen, Goran Hauser, Dimitrinka Nikolova, Christian Gluud – 1 October 2018

1 October 2018